Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

With Trumps tariffs poised to disrupt global pharma trade, industry stakeholders see opportunities for India, provided it ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...

Big Pharma continues fighting nationwide to block access to a vital drug program ― including here in Oklahoma.

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

Tauqeerul Haq said that since July 2024, Pakistan has witnessed an increase of 52 per cent in pharmaceutical exports while ...

Amidst the voluminous commentaries, blogs, tweets, panels and papers about the future of the pharma industry, in some circles certain thoughts seem to be becoming articles of faith: 1 ...

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.